Alkermes' Novel Schizophrenia Drug Shows Less Weight Gain, Addressing Top Patient Complaint - AJMC.com Managed Markets Network

Alkermes' Novel Schizophrenia Drug Shows Less Weight Gain, Addressing Top Patient Complaint  AJMC.com Managed Markets NetworkStudies presented in posters at the 175th Annual Meeting of the American Psychiatric Association demonstrated that the combination of olanzapine and ...